Ipsen

About:

Ipsen is a global specialty-driven biopharmaceutical company focused on innovation and specialty care.

Website: http://www.ipsen.com

Twitter/X: Ipsengroup

Description:

Ipsen is a global specialty-driven biopharmaceutical company focused on innovation and specialty care. Ipsen develops and commercializes innovative medicines in three key therapeutic areas: oncology, neuroscience, and rare disease. Its dedication to oncology is exemplified by its expanding portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma, and pancreatic cancer.

Total Funding Amount:

22M GBP

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

Boulogne-billancourt, Ile-de-France, France

Founded Date:

1929-01-01

Contact Email:

contact.web(AT)ipsen.com

Founders:

Henri Beaufour

Number of Employees:

1001-5000

Last Funding Date:

2017-11-20

IPO Status:

Public

Industries:

© 2025 bioDAO.ai